Hanesbrands (NYSE:HBI – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.510-0.550 for the period, compared to the consensus earnings per share estimate of 0.520. The company issued revenue guidance of $3.5 billion-$3.5 billion, compared to the consensus revenue estimate of $3.6 billion. Hanesbrands also updated its Q1 2025 guidance to 0.020-0.020 EPS.
Hanesbrands Trading Down 18.2 %
NYSE:HBI traded down $1.40 during mid-day trading on Thursday, reaching $6.27. The company’s stock had a trading volume of 30,860,928 shares, compared to its average volume of 5,733,473. The stock has a market cap of $2.21 billion, a P/E ratio of -9.49 and a beta of 1.63. Hanesbrands has a twelve month low of $4.06 and a twelve month high of $9.10. The company has a debt-to-equity ratio of 21.50, a current ratio of 1.49 and a quick ratio of 0.90. The company’s fifty day simple moving average is $8.25 and its two-hundred day simple moving average is $7.45.
Hanesbrands (NYSE:HBI – Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The textile maker reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.03. Hanesbrands had a positive return on equity of 44.72% and a negative net margin of 5.24%. On average, equities analysts predict that Hanesbrands will post 0.39 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Stock Report on HBI
Hanesbrands Company Profile
Hanesbrands Inc, a consumer goods company, designs, manufactures, sources, and sells a range of range of innerwear apparels for men, women, and children in the Americas, Europe, the Asia pacific, and internationally. The company operates through three segments: Innerwear, Activewear, and International.
Featured Stories
- Five stocks we like better than Hanesbrands
- What is a SEC Filing?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- How to Invest in Biotech Stocks
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Hanesbrands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanesbrands and related companies with MarketBeat.com's FREE daily email newsletter.